RESTON, Va., Oct. 13 /PRNewswire-FirstCall/ -- PRA International , a leading global clinical research organization, was named today to the 2006 Forbes list of the 200 Best Small Companies. Forbes ranked PRA International, the only clinical research organization on this year’s list, as the 48th top U.S. small company.
“Being recognized by Forbes is truly an honor and a reflection of the dedication of our employees to meet our clients’ needs,” said President and CEO Pat Donnelly. “It recognizes PRA International’s growth pattern over recent years and our global leadership position in the drug development industry.”
To be included in the Forbes list, a company must be a solid, consistent performer with a strong record over the past 12-month and five-year periods, and positioned for further growth. PRA grew considerably in 2006, acquiring facilities in the Netherlands and India to expand its early development services, bioanalytical laboratory services, and clinical and data management operations. In its more than 25 years, PRA International has developed a global presence with more than 2,700 employees in 30 offices on six continents.
PRA International
PRA International is one of the world’s leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, South America, Africa, Australia, and Asia. PRA, an ISO 9001:2000 registered company, delivers services to its clients through a unique approach called Project Assurance(R), which represents the Company’s commitment to reliable service delivery, program-level therapeutic expertise, easy, global access to knowledge, and involved senior management. To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.
PRA International
CONTACT: John Lewis, Director, Marketing and Public Relations of PRAInternational, +1-703-464-6338, lewisjohn@praintl.com
Web site: http://www.prainternational.com/
